As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
The first thing to shift is usually sleep
Josefa has been amazingquick to respond and incredibly helpful
Choose an SPF, or sun protection factor, of 15 or higher and reapply every couple of hours when you are in the sun
The researchers established a 5-compound (5C) protocol, consisting of SB431542, forskolin, DAPT (Notch inhibitor), IWP2 (Wnt inhibitor), and LDN193189 (BMP inhibitor) to suppress the expression of epithelial to mesenchymal transition marker genes (Xiang et al., 2019)
Strikingly, we observed a pronounced decrease in biofilm formation within the GR-deficient strain (Figure 1E)